GlassScriptPhysician profile
Gregory S Carlson
NPI 1740822576
$4,877.20
in general payments reported to CMS, 2019-2025
31 companies · $920 in 2025
The $920 reported for 2025 was more than what 84% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $242 · 2023: $1,129 · 2024: $2,586 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,636.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,635.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $766.72 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Glaxosmithkline, LLC. | $396.07 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $365.49 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Dexcom, INC. | $347.36 | 2024-2025 | Dexcom G6 Transmitter, Dexcom G7 Gss (161) |
| Astellas Pharma US INC | $342.87 | 2023-2025 | Veozah |
| Amgen INC. | $337.47 | 2023-2025 | Evenity, Repatha, Prolia |
| Eisai INC. | $239.17 | 2024-2025 | |
| Novo Nordisk INC | $231.65 | 2021-2024 | Rybelsus, Ozempic |
| Exact Sciences Corporation | $204.84 | 2023-2025 | Cologuard Collection Kit |
| Medtronic, INC. | $186.50 | 2024-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Abbvie INC. | $183.76 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $164.01 | 2023-2025 | Gemtesa |
| Lilly USA, LLC | $145.26 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Corium, LLC | $144.17 | 2023 | Adlarity |
| Bayer Healthcare Pharmaceuticals INC. | $117.88 | 2023-2024 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.01 | 2024-2025 | Ofev |
| Pfizer INC. | $98.68 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $85.91 | 2024-2025 | |
| Arbor Pharmaceuticals, INC. | $67.89 | 2021 | |
| Dynavax Technologies Corporation | $55.82 | 2023-2025 | Heplisav-B |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.69 | 2023-2024 | Cycloset, Trulance, Xifaxan |
| Inspire Medical Systems, INC. | $38.77 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $36.90 | 2024 | Spravato |
| Esperion Therapeutics, INC. | $35.12 | 2021 | |
| Avvisto Therapeutics, LLC | $33.11 | 2024 | Cycloset |
| Phathom Pharmaceuticals, INC. | $27.21 | 2024 | Voquezna |
| Viatris Specialty LLC | $17.29 | 2025 | Yupelri |
| Alnylam Pharmaceuticals INC. | $17.25 | 2021 | |
| Bioventus LLC | $16.81 | 2023 | Durolane |
| Opko Pharmaceuticals, LLC | $15.52 | 2024 | Rayaldee |
| Corcept Therapeutics | $15.00 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Carlson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.